CN114982866A - Premixed feed additive capable of improving diarrhea of young animals and preparation method thereof - Google Patents
Premixed feed additive capable of improving diarrhea of young animals and preparation method thereof Download PDFInfo
- Publication number
- CN114982866A CN114982866A CN202210811754.XA CN202210811754A CN114982866A CN 114982866 A CN114982866 A CN 114982866A CN 202210811754 A CN202210811754 A CN 202210811754A CN 114982866 A CN114982866 A CN 114982866A
- Authority
- CN
- China
- Prior art keywords
- parts
- preparation
- diarrhea
- feed additive
- young animals
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 46
- 206010012735 Diarrhoea Diseases 0.000 title claims abstract description 36
- 241001465754 Metazoa Species 0.000 title claims abstract description 26
- 239000003674 animal food additive Substances 0.000 title claims abstract description 14
- 235000019687 Lamb Nutrition 0.000 claims abstract description 5
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 22
- 239000002994 raw material Substances 0.000 claims description 22
- 102000004190 Enzymes Human genes 0.000 claims description 16
- 108090000790 Enzymes Proteins 0.000 claims description 16
- 229940088598 enzyme Drugs 0.000 claims description 16
- 241001145009 Sophora alopecuroides Species 0.000 claims description 13
- 235000007303 Thymus vulgaris Nutrition 0.000 claims description 13
- 229920001184 polypeptide Polymers 0.000 claims description 13
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 13
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 13
- MFBOGIVSZKQAPD-UHFFFAOYSA-M sodium butyrate Chemical compound [Na+].CCCC([O-])=O MFBOGIVSZKQAPD-UHFFFAOYSA-M 0.000 claims description 13
- 239000001585 thymus vulgaris Substances 0.000 claims description 13
- 239000000284 extract Substances 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 244000063299 Bacillus subtilis Species 0.000 claims description 11
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 11
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 11
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 11
- 150000001746 carotenes Chemical class 0.000 claims description 11
- 235000005473 carotenes Nutrition 0.000 claims description 11
- 229960000304 folic acid Drugs 0.000 claims description 11
- 235000019152 folic acid Nutrition 0.000 claims description 11
- 239000011724 folic acid Substances 0.000 claims description 11
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 claims description 11
- 239000008518 lycium barbarum polysaccharide Substances 0.000 claims description 7
- 244000241838 Lycium barbarum Species 0.000 claims description 6
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 6
- 235000015468 Lycium chinense Nutrition 0.000 claims description 6
- 150000004676 glycans Chemical class 0.000 claims description 6
- 229920001282 polysaccharide Polymers 0.000 claims description 6
- 239000005017 polysaccharide Substances 0.000 claims description 6
- 108010011619 6-Phytase Proteins 0.000 claims description 5
- 239000004382 Amylase Substances 0.000 claims description 5
- 102000013142 Amylases Human genes 0.000 claims description 5
- 108010065511 Amylases Proteins 0.000 claims description 5
- 241000194108 Bacillus licheniformis Species 0.000 claims description 5
- 101710130006 Beta-glucanase Proteins 0.000 claims description 5
- 241000186000 Bifidobacterium Species 0.000 claims description 5
- 108010059892 Cellulase Proteins 0.000 claims description 5
- 241000193171 Clostridium butyricum Species 0.000 claims description 5
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 claims description 5
- 241000194031 Enterococcus faecium Species 0.000 claims description 5
- 102000004882 Lipase Human genes 0.000 claims description 5
- 108090001060 Lipase Proteins 0.000 claims description 5
- 239000004367 Lipase Substances 0.000 claims description 5
- 108010059820 Polygalacturonase Proteins 0.000 claims description 5
- 102000005840 alpha-Galactosidase Human genes 0.000 claims description 5
- 108010030291 alpha-Galactosidase Proteins 0.000 claims description 5
- 235000019418 amylase Nutrition 0.000 claims description 5
- 229940106157 cellulase Drugs 0.000 claims description 5
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 5
- 235000019421 lipase Nutrition 0.000 claims description 5
- 229940085127 phytase Drugs 0.000 claims description 5
- 241000235342 Saccharomycetes Species 0.000 claims description 3
- -1 beta-mannase Proteins 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims 4
- 230000000996 additive effect Effects 0.000 claims 4
- 240000002657 Thymus vulgaris Species 0.000 claims 2
- 244000309466 calf Species 0.000 abstract description 16
- 241000283903 Ovis aries Species 0.000 abstract description 11
- 230000003115 biocidal effect Effects 0.000 abstract description 10
- 230000035755 proliferation Effects 0.000 abstract description 6
- 206010059866 Drug resistance Diseases 0.000 abstract description 5
- 230000000968 intestinal effect Effects 0.000 abstract description 5
- 238000009395 breeding Methods 0.000 abstract description 4
- 230000001488 breeding effect Effects 0.000 abstract description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 3
- 230000036541 health Effects 0.000 abstract description 2
- 235000021050 feed intake Nutrition 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 241000246358 Thymus Species 0.000 description 11
- 244000052616 bacterial pathogen Species 0.000 description 9
- 210000000813 small intestine Anatomy 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 230000036039 immunity Effects 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 5
- 229940088710 antibiotic agent Drugs 0.000 description 5
- 230000029087 digestion Effects 0.000 description 4
- 244000045947 parasite Species 0.000 description 4
- 108091005804 Peptidases Proteins 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 210000003022 colostrum Anatomy 0.000 description 3
- 235000021277 colostrum Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 230000003071 parasitic effect Effects 0.000 description 3
- 235000019419 proteases Nutrition 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 206010004016 Bacterial diarrhoea Diseases 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 206010051511 Viral diarrhoea Diseases 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 108010055059 beta-Mannosidase Proteins 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 230000007969 cellular immunity Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000004727 humoral immunity Effects 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 210000004767 rumen Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- CUJMCPPBTUATEJ-UHFFFAOYSA-N 1-(3-methyl-4-oxido-1-oxoquinoxalin-1-ium-2-yl)ethanone Chemical compound C1=CC=C2[N+](=O)C(C(=O)C)=C(C)N([O-])C2=C1 CUJMCPPBTUATEJ-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 108010026389 Gramicidin Proteins 0.000 description 1
- 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 108010002386 Interleukin-3 Proteins 0.000 description 1
- 206010049443 Intestinal villi atrophy Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 108010040201 Polymyxins Proteins 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- RKLXDNHNLPUQRB-TVJUEJKUSA-N chembl564271 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]2C(C)SC[C@H](N[C@@H](CC(N)=O)C(=O)NC(=O)[C@@H](NC2=O)CSC1C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NC(=C)C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@H]1NC(=O)C(=C\C)/NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]2NC(=O)CNC(=O)[C@@H]3CCCN3C(=O)[C@@H](NC(=O)[C@H]3N[C@@H](CC(C)C)C(=O)NC(=O)C(=C)NC(=O)CC[C@H](NC(=O)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC=4C5=CC=CC=C5NC=4)CSC3)C(O)=O)C(C)SC2)C(C)C)C(C)SC1)C1=CC=CC=C1 RKLXDNHNLPUQRB-TVJUEJKUSA-N 0.000 description 1
- 229960001229 ciprofloxacin hydrochloride Drugs 0.000 description 1
- DIOIOSKKIYDRIQ-UHFFFAOYSA-N ciprofloxacin hydrochloride Chemical compound Cl.C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 DIOIOSKKIYDRIQ-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 229960004905 gramicidin Drugs 0.000 description 1
- ZWCXYZRRTRDGQE-SORVKSEFSA-N gramicidina Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC=O)C(C)C)CC(C)C)C(=O)NCCO)=CNC2=C1 ZWCXYZRRTRDGQE-SORVKSEFSA-N 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 229960000988 nystatin Drugs 0.000 description 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 108010082567 subtilin Proteins 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/189—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/01—Carboxylic ester hydrolases (3.1.1)
- C12Y301/01003—Triacylglycerol lipase (3.1.1.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
- C12Y301/03026—4-Phytase (3.1.3.26), i.e. 6-phytase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01001—Alpha-amylase (3.2.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01004—Cellulase (3.2.1.4), i.e. endo-1,4-beta-glucanase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01011—Dextranase (3.2.1.11)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01022—Alpha-galactosidase (3.2.1.22)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01025—Beta-mannosidase (3.2.1.25), i.e. mannanase
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Food Science & Technology (AREA)
- Molecular Biology (AREA)
- Animal Husbandry (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medical Informatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Alternative & Traditional Medicine (AREA)
- Oncology (AREA)
- Physiology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
Abstract
The invention discloses a premixed feed additive capable of improving diarrhea of young animals and a preparation method thereof, and the premixed feed additive can be applied to breeding production of calves and lambs. The invention can enhance the resistance of calves and lambs, promote the proliferation of intestinal villi, regulate the health of intestinal tracts, obviously reduce the diarrhea rate and effectively improve the feed intake and daily gain. The product has the characteristics of broad-spectrum antibiosis, no antibiotic and no drug resistance. The product is a premixed feed additive in small packages, can be produced in large batch, is convenient to use, safe and effective, and can be widely popularized in calf and lamb breeding enterprises and farmers.
Description
Technical Field
The invention relates to the field of premix for calves and lambs, in particular to a premix feed additive capable of improving diarrhea of young animals and a preparation method thereof.
Background
An active immune system is not established in the early stage of calves and lambs, passive immunity is obtained by feeding colostrums, immunoglobulin in the colostrums can be absorbed by small intestines of the born animals only within 24 hours after birth, and the immunoglobulin cannot be obtained by feeding milk in the later stage, so that the passive immunity is gradually reduced from the beginning after the colostrums are fed. The active immunity is gradually established only after the calves and the lambs are born for about 15 days, so that the calves and the lambs have high diarrhea rate and high death rate in the period of 1 to 15 days of the birth, and huge loss is caused to vast breeding enterprises and farmers. The development of a high-efficiency and safe diarrhea prevention and treatment product is significant to breeding enterprises and farmers.
The diarrhea prevention and treatment is usually carried out by injecting antibiotics, and gentamicin or mequindox can be used for drenching calf diarrhea caused by escherichia coli; ciprofloxacin hydrochloride can be injected to the calf diarrhea caused by salmonella; the initial stage of diarrhea caused by clostridium welchii can be treated by penicillin. The technical requirements of veterinarians during diagnosis and treatment are high, the diarrhea type needs to be accurately judged to be effectively treated, and bacterial assay equipment is lacked in a pasture. Meanwhile, the large amount of antibiotic treatment affects the rumen and small intestine flora reproduction of young animals, so that the digestive system in the later stage develops slowly and the weight gain is affected. If antibiotics are excessively used, residual antibiotics in the body can be transferred to the human body through food, so that pathogenic bacteria generate drug resistance, the curative effect of the drug is influenced, and the health of the human is endangered.
Disclosure of Invention
The invention aims to: in order to solve the technical problems that the diarrhea rate of early-stage calves and lambs is high, the rumen and small intestine flora proliferation of the calves and the lambs can be inhibited by using antibiotic treatment, and pathogenic bacteria generate drug resistance, a premixed feed additive capable of improving the diarrhea of young animals and a preparation method thereof are provided.
In order to achieve the purpose, the invention provides the following technical scheme: a premixed feed additive capable of improving diarrhea of young animals and a preparation method thereof comprise the following raw materials: wolfberry polysaccharide, thyme extract, sophora alopecuroide, bacillus subtilis culture, polypeptide, sodium butyrate, an enzyme preparation, a microecological preparation, carotene, VB, folic acid and the balance of a carrier.
By adopting the technical method, the raw materials are comprehensively prepared, and the antibacterial action and the antioxidation in the lycium barbarum polysaccharide, the polypeptide, the thyme extract and the sophora alopecuroides are utilized to kill pathogenic bacteria and parasites, inhibit the reproduction of the pathogenic bacteria and the parasites, and regulate and improve diarrhea caused by bacteria and the parasites. Meanwhile, the microecological preparation is used for regulating the balance of intestinal flora of calves and lambs, the sodium butyrate is used for promoting the proliferation of intestinal villi, and the enzyme preparation is matched to improve the digestion capacity of the calves and the lambs, so that the phenomena of nutritional diarrhea such as calf and lamb intestinal immune injury, intestinal villi atrophy, digestive enzyme level reduction, nutrient absorption rate reduction and the like caused by diarrhea or unreasonable feed formula design are slowed down and improved, and the diarrhea of the calves and the lambs is systematically prevented and treated.
Further, the first raw material composition comprises 3-6 parts of wolfberry polysaccharide, 4-8 parts of thyme extract, 5-10 parts of sophora alopecuroide, 5-9 parts of bacillus subtilis culture, 3-8 parts of polypeptide, 6-12 parts of sodium butyrate, 3-10 parts of an enzyme preparation, 3-7 parts of a microecological preparation, 3-5 parts of carotene, VB1-2 parts, 4-6 parts of folic acid and the balance of a carrier.
By adopting the technical scheme, bioactive substances in the lycium barbarum polysaccharide can be utilized to promote immune functions of T, B, CTL, NK, macrophage and the like and promote generation of cytokines such as IL-2, IL-3, TNF beta and the like, so that the immunity of young livestock is improved. The extracts of sophora alopecuroide and thyme can improve the oxidation resistance of organisms, thereby enhancing the cellular immunity and the humoral immunity and assisting in inhibiting pathogenic bacteria. The Bacillus subtilis culture contains active substances such as subtilin, polymyxin, nystatin, gramicidin, etc., and the active substances can inhibit pathogenic bacteria or endogenous infection condition pathogenic bacteria. The basic polypeptide has broad-spectrum antibacterial effect, and can rapidly kill target to replace antibiotics. The sodium butyrate can promote the villus proliferation of small intestine, increase the absorption area of small intestine, the microecological preparation can adjust the flora balance of small intestine, and the digestion and absorption capacity of calf and lamb can be enhanced by combining the microecological preparation with an enzyme preparation. Carotene, VB and folic acid are components of enzyme synthesis in animals, and vitamin balance can help animals to better regulate body metabolism.
Further, the enzyme preparation in the first raw material composition comprises one or more of xylanase, beta-glucanase, beta-mannase, cellulase, alpha-galactosidase, pectinase, phytase, albumen powder, amylase and lipase
Further, the microecological preparation in the first raw material composition comprises one or more of enterococcus faecium, clostridium butyricum, bacillus licheniformis, bifidobacterium and yeast.
Compared with the prior art, the invention has the beneficial effects that:
1. compared with antibiotic treatment, the present invention has wide antibiotic effect, and Lycium barbarum polysaccharide contains bioactive matter and can strengthen the immunity of immunocyte. The sophora alopecuroide and the thyme can improve the oxidation resistance of organisms, the bacillus and the polypeptide have the direct inhibition effect on pathogenic bacteria, and the activity of various pathogenic bacteria can be widely inhibited through combined preparation, so that the bacterial, viral and parasitic diarrhea can be comprehensively prevented.
2. Compared with antibiotic treatment, the invention can not generate drug resistance, most of antibiotics can weaken the treatment effect after long-term use, even has the problem of antibiotic residue, and the antibiotic residue is transduced into the human body through food to influence the treatment effect of human diseases. The raw materials used in the invention are mostly organic substances, have no drug resistance and no residue, and can be used in a large range;
3. the invention does not produce side effect to animals in the using process, the antibiotic can destroy the flora of gastrointestinal tract in the using process, and can cure diarrhea in a short time, but can weaken the digestion capability of animals in stages to influence weight gain. The invention can not inhibit the function of animal gastrointestinal flora, and simultaneously, the sodium butyrate can promote the proliferation of intestinal villi, increase the absorption area of food and small intestine, improve the digestibility of animals and relieve the negative effect of diarrhea on animals.
Detailed Description
The technical solution of the present invention will be further specifically described below by way of examples.
The animal diarrhea is divided into 4 types of viral diarrhea, bacterial diarrhea, parasitic diarrhea and nutritional diarrhea, and the invention mainly treats the diarrhea from 2 aspects:
1. improving animal immunity and oxidation resistance, enhancing cellular immunity and humoral immunity, and inhibiting activity of virus, bacteria and parasite, thereby treating viral diarrhea, bacterial diarrhea and parasitic diarrhea.
2. Improving digestion ability of animals, promoting small intestine villus proliferation and gastrointestinal tract flora balance, and treating nutritional diarrhea.
The first embodiment is as follows:
the premixed feed additive capable of improving the diarrhea of young animals and the preparation method thereof are characterized by comprising the following raw materials: wolfberry polysaccharide, thyme extract, sophora alopecuroide, bacillus subtilis culture, polypeptide, sodium butyrate, enzyme preparation, microecological preparation, carotene, VB, folic acid and the balance of carrier.
Further, the raw materials for improving the diarrhea route of young animals comprise 5 parts of lycium barbarum polysaccharide, 4 parts of thyme extract, 4 parts of sophora alopecuroides, 6 parts of bacillus subtilis culture, 8 parts of polypeptide, 6 parts of sodium butyrate, 4 parts of an enzyme preparation, 5 parts of a microecological preparation, 5 parts of carotene, 1 part of VB, 4 parts of folic acid and the balance of a carrier.
Further, the enzyme preparation in the first raw material composition comprises one or more of xylanase, beta-glucanase, beta-mannase, cellulase, alpha-galactosidase, pectinase, phytase, protease, amylase and lipase.
Further, the microecological preparation in the first raw material composition comprises one or more of enterococcus faecium, clostridium butyricum, bacillus licheniformis, bifidobacterium and yeast.
Example two:
the premixed feed additive capable of improving the diarrhea of young animals and the preparation method thereof are characterized by comprising the following raw materials: wolfberry polysaccharide, thyme extract, sophora alopecuroide, bacillus subtilis culture, polypeptide, sodium butyrate, microecological preparation, carotene, VB, folic acid and the balance of carrier.
Further, the raw materials for improving the diarrhea route of young animals comprise 3 parts of lycium barbarum polysaccharide, 6 parts of thyme extract, 6 parts of sophora alopecuroides, 9 parts of bacillus subtilis culture, 8 parts of polypeptide, 10 parts of sodium butyrate, 6 parts of an enzyme preparation, 6 parts of a microecological preparation, 5 parts of carotene, VB2 parts, 4 parts of folic acid and the balance of a carrier.
Further, the enzyme preparation in the first raw material composition comprises one or more of xylanase, beta-glucanase, beta-mannanase, cellulase, alpha-galactosidase, pectinase, phytase, protease, amylase and lipase.
Further, the microecological preparation in the first raw material composition comprises one or more of enterococcus faecium, clostridium butyricum, bacillus licheniformis, bifidobacterium and saccharomycetes. Example three:
the premixed feed additive capable of improving diarrhea of young animals and the preparation method thereof are characterized by comprising the following raw materials: wolfberry polysaccharide, thyme extract, sophora alopecuroide, bacillus subtilis culture, polypeptide, sodium butyrate, microecological preparation, carotene, VB, folic acid and the balance of carrier.
Further, the raw materials for improving the diarrhea route of young animals comprise 6 parts of lycium barbarum polysaccharide, 8 parts of thyme extract, 6 parts of sophora alopecuroides, 5 parts of bacillus subtilis culture, 3 parts of polypeptide, 8 parts of sodium butyrate, 10 parts of an enzyme preparation, 7 parts of a microecological preparation, 5 parts of carotene, VB2 parts, 5 parts of folic acid and the balance of a carrier.
Further, the enzyme preparation in the first raw material composition comprises one or more of xylanase, beta-glucanase, beta-mannanase, cellulase, alpha-galactosidase, pectinase, phytase, protease, amylase and lipase.
Further, the microecological preparation in the first raw material composition comprises one or more of enterococcus faecium, clostridium butyricum, bacillus licheniformis, bifidobacterium and saccharomycetes.
It will be evident to those skilled in the art that the invention is not limited to the details of the foregoing illustrative embodiments, and that the present invention may be embodied in other specific forms without departing from the spirit or essential attributes thereof. The present embodiments are therefore to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.
Claims (4)
1. The premixed feed additive capable of improving diarrhea of young animals and the preparation method thereof are characterized by comprising the following raw materials: wolfberry polysaccharide, thyme extract, sophora alopecuroide, bacillus subtilis culture, polypeptide, sodium butyrate, enzyme preparation, microecological preparation, carotene, VB, folic acid and the balance of carrier.
2. The premix feed additive for improving diarrhea in young animals according to claim 1, wherein the premix feed additive comprises: the first raw material composition comprises 3-6 parts of lycium barbarum polysaccharide, 4-8 parts of thyme extract, 5-10 parts of sophora alopecuroides, 5-9 parts of bacillus subtilis culture, 3-8 parts of polypeptide, 6-12 parts of sodium butyrate, 3-10 parts of an enzyme preparation, 3-7 parts of a microecological preparation, 3-5 parts of carotene, VB1-2 parts, 4-6 parts of folic acid and the balance of a carrier.
3. The additive premix capable of reducing fat of lamb carcasses and the preparation method thereof as claimed in claim 1, wherein the additive premix comprises the following components: the enzyme preparation in the first raw material composition comprises one or more of xylanase, beta-glucanase, beta-mannase, cellulase, alpha-galactosidase, pectinase, phytase, albumen powder, amylase and lipase.
4. The additive premix capable of reducing fat of lamb carcasses and the preparation method thereof as claimed in claim 1, wherein the additive premix comprises the following components: the microecological preparation in the first raw material composition comprises one or more of enterococcus faecium, clostridium butyricum, bacillus licheniformis, bifidobacterium and saccharomycetes.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210811754.XA CN114982866A (en) | 2022-07-12 | 2022-07-12 | Premixed feed additive capable of improving diarrhea of young animals and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210811754.XA CN114982866A (en) | 2022-07-12 | 2022-07-12 | Premixed feed additive capable of improving diarrhea of young animals and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114982866A true CN114982866A (en) | 2022-09-02 |
Family
ID=83018977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210811754.XA Pending CN114982866A (en) | 2022-07-12 | 2022-07-12 | Premixed feed additive capable of improving diarrhea of young animals and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114982866A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102232467A (en) * | 2011-04-15 | 2011-11-09 | 北京康华远景科技有限公司 | Livestock and poultry anti-diarrheal feed additive and preparation method thereof |
CN103125750A (en) * | 2011-11-21 | 2013-06-05 | 南通中科睿智科技服务有限公司 | Nutrition additive of young bird livestock and poultry feed |
CN104082528A (en) * | 2013-11-20 | 2014-10-08 | 朱建国 | Feed additive and preparation method thereof |
CN106879826A (en) * | 2017-03-17 | 2017-06-23 | 青岛普维动物保健品有限公司 | A kind of animal feed additive comprising plant extracts and organic acid and application |
CN109170201A (en) * | 2018-08-24 | 2019-01-11 | 江苏隆达生物科技有限公司 | A kind of feed addictive and production method with bacteriostasis containing fructooligosaccharide and thyme extract |
-
2022
- 2022-07-12 CN CN202210811754.XA patent/CN114982866A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102232467A (en) * | 2011-04-15 | 2011-11-09 | 北京康华远景科技有限公司 | Livestock and poultry anti-diarrheal feed additive and preparation method thereof |
CN103125750A (en) * | 2011-11-21 | 2013-06-05 | 南通中科睿智科技服务有限公司 | Nutrition additive of young bird livestock and poultry feed |
CN104082528A (en) * | 2013-11-20 | 2014-10-08 | 朱建国 | Feed additive and preparation method thereof |
CN106879826A (en) * | 2017-03-17 | 2017-06-23 | 青岛普维动物保健品有限公司 | A kind of animal feed additive comprising plant extracts and organic acid and application |
CN109170201A (en) * | 2018-08-24 | 2019-01-11 | 江苏隆达生物科技有限公司 | A kind of feed addictive and production method with bacteriostasis containing fructooligosaccharide and thyme extract |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ahmed et al. | Comparison of single and blend acidifiers as alternative to antibiotics on growth performance, fecal microflora, and humoral immunity in weaned piglets | |
Alugongo et al. | Effects of Saccharomyces cerevisiae fermentation products on dairy calves: Performance and health | |
Latorre et al. | Evaluation of germination, distribution, and persistence of Bacillus subtilis spores through the gastrointestinal tract of chickens | |
JP2020525034A (en) | Bacillus subtilis strain with probiotic activity | |
CN106036040A (en) | Mixed feed additive | |
Tarkhani et al. | The effects of host-associated Enterococcus faecium CGMCC1. 2136 on serum immune parameters, digestive enzymes activity and growth performance of the Caspian roach (Rutilus rutilus caspicus) fingerlings | |
EP1867238A1 (en) | Feeding stuff composition comprising proliferation promoting agent for bifidus bacteria and use of the same | |
Ren et al. | Immune response of piglets receiving mixture of formic and propionic acid alone or with either capric acid or bacillus licheniformis after Escherichia coli challenge | |
US20140037605A1 (en) | Anticoccidial composition | |
Kyriakis | New aspects of the prevention and/or treatment of the major stress induced diseases of the early weaned piglet. | |
EP0681787A2 (en) | Use of an enzyme for manufacturing an agent for the treatment and/or prophylaxis of coccidiosis | |
Hosseinabadi et al. | The effect of feeding of bacterial probiotic in milk or starter on growth performance, health, blood and rumen parameters of suckling calves | |
US11260084B2 (en) | Feed additive formulation and methods of making and using the same | |
CN114982866A (en) | Premixed feed additive capable of improving diarrhea of young animals and preparation method thereof | |
CN111109468A (en) | Compound feed for poultry and preparation method thereof | |
CN107467670B (en) | Probiotic preparation and preparation method and application thereof | |
KR102443122B1 (en) | Pig feed method containing feed additives | |
CN104824352A (en) | Poultry feed capable of promoting digestion | |
CN104366109A (en) | Antibiotic-free concentrated feed for young chicken and preparation method thereof | |
Panitsidis et al. | Probiotics, prebiotics, paraprobiotics, postbiotics | |
Stein | Feeding the pigs’ immune system and alternatives to antibiotics | |
CN112136970A (en) | Piglet nursing compound feed and preparation method thereof | |
Nugusa et al. | Review on probiotics and prebiotics' in healthcare poultry's prevention of intestinal bacterial infection | |
Yulianto et al. | The potency of Bifidobacterium spp. as an alternative to antibiotic growth promoters on feed conversion ratio, feed efficiency, and nutrient intake in laying hens | |
Burel | Alternatives to antimicrobial growth promoters (AGPs) in animal feed |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20220902 |